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The first example of molecular docking of the SARS-CoV-2 main protease for
COVID-19 [Mpro, Protein Data Bank (PDB) code 7BQY] by a chalcone-based
ligand, namely, (E)-1-(2,4-dichlorophenyl)-3-[4-(morpholin-4-yl)phenyl]prop-2-
en-1-one, C19H17Cl2NO2, I, is presented. Two-dimensional (2D) LIGPLOT
representations calculated for the inhibitor N3, viz. N-{[(5-methylisoxazol-3-yl)-
carbonyl]alanyl}-l-valyl-N1-((1R,2Z)-4-(benzyloxy)-4-oxo-1-{[(3R)-2-oxopyrrol-
idin-3-yl]methyl}but-2-enyl)-l-leucinamide, and 7BQY are included for com-
parison with our chalcone-based complexes. The binding affinity of our chalcone
ligand with 7BQY is 7.0 kcal mol1, a high value which was attributed to the
presence of a hydrogen bond, together with many hydrophobic interactions
between the drug and the active amino acid residues of the receptor. Docking
studies were also performed, employing rigid and flexible binding modes for the
ligand. The superposition of N3 and the chalcone docked into the binding pocket
of 7BQY is also presented. The synthesis, single-crystal structure, Hirshfeld
surface analysis (HSA) and spectral characterization of heterocyclic chalcone-
based compound I, are also presented. The molecules are stacked, with normal
– interactions, in the crystal.
1. Introduction
COVID-19 is a worldwide disease that has currently infected
over 47 million individuals with a death toll rate ranging from
5 to 9%. There are numerous ongoing efforts in drug discovery
to control the awful impact of the disease on our lives (Jin et
al., 2020; Dhama et al., 2020; Zhang & Liu, 2020; Peele et al.,
2020; Singhal, 2020). The SARS-CoV-2 main protease (Mpro)
plays an important role in viral replication. In fact, it is a key
target for COVID-19 drug discovery due to its low similarity
with human genes. Other important roles in understanding the
molecular mechanism in drug discovery are the binding affi-
nity and structure of protein–drug complexes; hence, Mpro is
well placed to serve as the primary drug target (Wang, 2020;
Kumar et al., 2020; Bhatia et al., 2020). Chalcones containing
heterocyclic substructures, e.g. 1,3-diphenyl-2-propen-1-one
(Fig. 1), and many related compounds have attracted much
interest because they show a range of pharmacological activ-
ities (Nowakowska, 2007; Kanagarajan & Gopalakrishnan,
2011; Thillainayagam et al., 2016; Fu et al., 2016; Burmaoglu et
al., 2020). Many reports have demonstrated that chalcone-
based compounds have contributed in antimalarial (Larsen et
al., 2005), antitumour (Awoussong et al., 2015), anti-inflam-
matory (Hsieh et al., 1998), anti-oxidant (Nowakowska, 2007),
antibacterial (Mallavadhani et al., 2014) and antifungal (Wu et
al., 2014a) drugs. Also, well-established evidence shows that
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chalcone-based compounds can be inhibitors against the cys-
teine proteases in the malarial parasite which are responsible
for the degradation of the host haemoglobin, known to be
useful for the preparation of the amino acid, mainly cysteine
(Cys) (Li et al., 1995). Furthermore, they show an exciting
healing feature, viz. relief of rheumatic pain (Nowakowska,
2007). Chalcones form a class of natural products present in
tea, fruits, spices and vegetables. They are part of the flavonoid
group comprising two aromatic rings joined by a three-carbon
,-unsaturated carbonyl arrangement (Fig. 1) (Zi & Simo-
neau, 2005).
We note, in this context, that chalcones can exist as Z- and/
or E-isomers. Thermodynamic studies show that the E-isomer
is the more stable (Larsen et al., 2005). The E- and Z-isomers
have been isolated and tested for their pharmacological
action; only relatively small differences in the biological
activities of the isolated isomers were observed (Larsen et al.,
2005).
At present, no effective clinical remedies are available for
the treatment of COVID-19 (Ren et al., 2020). Hence, the race
for the characterization and identification of a new treatment
candidate to inhibit binding between the COVID-19 main
protease (Mpro) and the angiotensin converting enzyme-2, on
the cell surface, is speeding up (Jin et al., 2020). In view of
these facts, we have been stimulated to screen, in silico, the
interaction between the main protease (7BQY) active site
with a heterocyclic chalcone-based ligand; we note that the
first protein–ligand docking method was published more than
three decades ago (Kuntz et al., 1982).
The X-ray structure of the COVID-19 main protease (Mpro)
bonded to the inhibitor N3, viz. N-[(5-methylisoxazol-3-yl)-
carbonyl]alanyl-l-valyl-N1-((1R,2Z)-4-(benzyloxy)-4-oxo-1-
{[(3R)-2-oxopyrrolidin-3-yl]methyl}but-2-enyl)-l-leucinamide,
has been determined and refined, first to a resolution of 2.1 Å
[Protein Data Bank (PDB) code 6LU7; Jin et al., 2020] and
later to a resolution of 1.7 Å (PDB code 7BQY; Liu et al.,
2020); the latter is therefore the preferred model for our
studies. Schematic diagrams of protein–ligand interactions
were generated using the LIGPLOT program (Wallace et al.,
1995); the plot for the inhibitor N3 in its complex with 7BQY
was used to identify the active sites and generate the receptor
grid for docking simulations.
We also describe the synthesis of a heterocyclic chalcone-
based compound (E)-1-(2,4-dichlorophenyl)-3-[4-(morpholin-
4-yl)phenyl]prop-2-en-1-one or 2,4-Cl2C6H3-CO-CH CH-
C6H4-cyclo-(NCH2CH2OCH2CH2), I (Scheme 1), and report
the single-crystal X-ray structure, Hirshfeld surface analysis
(HSA) and spectral characterization, and from molecular
docking studies, the likely binding of this molecule in the
active site of 7BQY.
2. Experimental
2.1. General characterization techniques
All chemicals were purchased from Sigma–Aldrich and
were used without further purification in the open atmosphere
and at room temperature. Carbon, hydrogen and nitrogen
contents were estimated on a CHN Model CE-440 Analyzer
and on an Elementar Vario EL III Carlo Erbo 1108. IR spectra
(/cm1) were recorded on an IRAffinity-1S Shimadzu
instrument, using KBr disks. 1H and 13C NMR spectra were
recorded with a Bruker AMX-400 spectrometer operating at
400 and 100 MHz using tetramethylsilane (TMS) as an inter-
nal standard.
2.2. Synthesis of chalcone I
To a stirred solution of 1-(2,4-dichlorophenyl)ethanone
(0.188 g, 1 mmol) and 4-(morpholin-4-yl)benzaldehyde (0.191 g,
1 mmol) in ethanol (20 ml) at 0–5 C was added dropwise 10%
NaOH (10 ml). The resulting mixture was brought slowly to
room temperature (25 C) and then stirred for 12 h. The
mixture was poured onto ice-cold water and acidified with
HCl. The precipitate obtained was filtered off, washed with
water (3  10 ml) and recrystallized from hot ethanol to
produce the title compound as yellow crystals in good
yield (74%; m.p. 139–142 C) (Scheme 1). 1H NMR (CDCl3,
400 MHz):  3.43 (s, 4H, NCH2CH2O), 3.65 (s, 4H,
NCH2CH2O), 6.03 and 6.07 (d, 2H, Ph), 7.50–8.03 (m,
remaining Ph and CH CH). IR (, cm1): 1512 and 1655
(C C), 1575 (C O), 1685 (C O), 2857 and 2972 (C—H
alkyl), 3089 (C—H aromatic). Analysis calculated (%) for
C19H17Cl2NO2: C 63.00, H 4.73, N 3.87; found: C 63.32, H 4.91,
N 4.05.
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Figure 1
The E and Z isomers of the chalcone basic structure.
2.3. Crystal structure analysis and refinement
H atoms were included in idealized positions and their
Uiso(H) values were set to ride on the Ueq values of the parent
C atoms. The absolute configuration is as shown in Fig. 2(a). In
the final difference map, the highest peak (ca 0.2 e Å3) was
near atom H18a. Experimental data for the crystals, the
diffraction intensity measurements and the refinement
procedure are given in Table 1.
2.4. Hirshfeld surface analysis
Hirshfeld surface analysis and the related two-dimensional
(2D) fingerprint plots were calculated using CrystalExplorer
(Version 17; Turner et al. 2017), which reads a structure input
file in CIF format.
2.5. Docking in silico studies
Docking studies of chalcone ligand I were performed using
the Autodock Vina wizard in PyRx 0.8 (available freely from
https://sourceforge.net/projects/pyrx/). This is a powerful
visualization engine, a more efficient and accurate tool than
AutoDock 4, and a valuable software program for molecular
docking (Allouche, 2012). The rigid and flexible binding
modes of I were explored for comparison. The settings in the
program include: Grid box (65, 65, 74 Å) centred at (6.057,
0.775, 22.695); energy range = 4 and exhaustiveness = 8;
number of active torsion bonds set to zero in the case of the
rigid ligand docking mode and four bonds for the flexible
docking ligand mode. The same modes are possible for the
protein using the default settings. AutoDock Vina offers two
types of charges: ‘Kollman’ (used as the default setting) and
‘Compute Gasteiger Charges’ (calculated based on electro-
negativity equilibration; these can be applied on ligands where
there are no partial charges, but may also be applied on the
protein as well). Gasteiger charges assume an overall net
neutral state for the molecular system, whereas Kollman
charges define values for each amino acid derived from the
corresponding electrostatic potential. The total Kollman
charge added for the protein in this study was 4, with a value of
zero for the ligand. The energy minimization of the protein was
performed using the default settings in Autodock Vina in PyRx.
The chalcone molecular structure was taken from the X-ray
analysis and the coordinates (in CIF format) were converted
to PDB style for input to Autodock Vina in PyRx. The
protease (PDB code 7BQY) was saved in PDB format after
deletion of the water molecules and the N3 ligand. The
PyMOL molecular viewer was used to present the output and
to measure the distances, angles and torsion angles among
atoms of interest (DeLano, 2004). The key residues that form
the substrate-binding pocket of 7BQY used in this study were
identified from the binding mode of the protease with N3
reported recently (Jin et al., 2020) using the 2D LIGPLOT
representation of the protein–ligand interactions in the com-
plex (Wallace et al., 1995); we note that these results confirm
those reported in Fig. 2 of the Extended Data of the article by
Jin et al., (2020).
3. Results and discussion
3.1. Crystal structure analysis
A major feature of the chalcone-based structure of this
study is that the keto–ethene group is shown to be the
E-isomer. This can be seen clearly in the conformation
(Fig. 2a) and the bond dimensions in the keto–ethene group
(Ravishankar et al., 2003).
Views of the chalcone molecule (with both the atom
numbering and electron-density details) are shown in Fig. 2.
X-ray analysis revealed that the molecule is a chain of three
planar groups, viz. a phenyl ring, a keto–ethene group and a
second phenyl group which is attached to a morpholine group
(Fig. 2a). There is a rotation about the C1—C7 bond so that
the normals to the planes of the C1–C6 phenyl ring and the
linking keto–ethene group are 54.71 (12) apart. The second
phenyl ring, C11–C16, is rotated only 6.9 (2) from the plane
of the keto–ethene group, indicating that the keto–ethene
fragment lies not far from the C11–C16 ring plane. The
dihedral angle between the two phenyl ring planes is
50.21 (5), which is equal to the largest from earlier reported
examples, e.g. 50.7 in 4-methylchalcone (Treadwell, 2006),
14.34 in 4-chlorochalcone (Li & Su, 1994) and 13.0 in chal-
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Crystal system, space group Monoclinic, P21
Temperature (K) 100
a, b, c (Å) 3.96521 (9), 16.7005 (4),
12.4252 (2)
 () 91.185 (2)
V (Å3) 822.63 (3)
Z 2
Radiation type Cu K
 (mm1) 3.64
Crystal size (mm) 0.15  0.13  0.12
Data collection
Diffractometer Rigaku XtaLAB Synergy Dualflex
HyPix
Absorption correction Multi-scan (CrysAlis PRO; Rigaku
OD, 2019)
Tmin, Tmax 0.790, 1.000
No. of measured, independent and







R[F 2 > 2(F 2)], wR(F 2), S 0.024, 0.064, 1.07
No. of reflections 3089
No. of parameters 217
No. of restraints 1
H-atom treatment H-atom parameters constrained
max, min (e Å
3) 0.18, 0.20
Absolute structure Flack x determined using 1385
quotients [(I+)  (I)]/
[(I+) + (I)] (Parsons et al., 2013)
Absolute structure parameter 0.002 (9)
Computer programs: CrysAlis PRO (Rigaku OD, 2019), SHELXT (Sheldrick, 2015a),
ORTEP-3 (Farrugia, 2012), SHELXL2018 (Sheldrick, 2015b) and WinGX (Farrugia,
2012).
cone itself (Wu et al., 2014b). Our chalcone derivative has a
torsion angle of 3.1 (4) for the O7—C7—C8—C9 moiety; this
is quite different from that in 4-methylchalcone (16.3; Li &
Su, 1994). There is almost a complete change of the torsion
angles upon the calculated interaction of our chalcone with
protease 7BQY (Table 2).
The three planar groups in our molecule are each stacked,
with normal – interactions, along the a axis with interplanar
distances of 3.65, 3.483 and 3.385 Å (Fig. 3). The C C and
C—C bonds in the bridging group are compared with other
chalcone structures (Table 3); the C7—C8 single bond is
generally slightly shorter than those reported, whereas
C8 C9 is a longer double bond.
The C1–C6 arene ring is overlaid on one side by the
corresponding ring in the molecule at (x + 1, y, z), with atom
C5 over the ring centre, and on the other side by the ring in the
molecule at (x  1, y, z), with atom C2 over the ring centre.
Similarly, the second ring has atom C15 of the molecule at
(x + 1, y, z) over the C11–C16 ring centre and, on the other
side, atom C12 of the molecule at (x  1, y, z) is close to the
ring centre. There are two further short intermolecular
contacts, described as ‘weak hydrogen bonds’, viz. C18—
H18A  O7i and C13—H13  O7i (see Table 4 for details).
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Figure 2
(a) View of a molecule of I, indicating the atom-numbering scheme.
Displacement ellipsoids are drawn at the 50% probability level. (b) A
mesh diagram of the compound showing the electron density around all
the atoms of the molecule using the CrystalExplorer program with CIF
data (Turner et al., 2017).
Table 2
Torsion angles () of the keto–ethene group in selected chalcone molecules and of the keto–ethene group after ligand–protein interaction.
C16—C11—C9—C8 C11—C9—C8—C7 C9—C8—C7—O7 C9—C8—C7—C1 C8—C7—C1—C6 Reference
7.4 (4) 177.70 (19) 3.1 (4) 179.78 (19) 128.2 (2) This study
35.7 177.6 20.2 162.9 47.3 This study*
11.0 176.8 16.3 163.0 157.5 Treadwell (2006)
12.8 178.5 7.0 173.0 169.0 Li & Su (1994)
2.5 169.5 11.8 179.8 163.8 Wu et al. (2014b)
7.1 179.9 8.5 170.7 166.8 Barsky et al. (2008); compound 3
Note: (*) the torsion angles for the keto–ethene after interaction with 7BQY.
Table 3
Bond lengths (Å) in the keto–ethene group in related chalcones
(Ravishankar et al., 2003).
O7—C7 C7—C8 C8 C9 Reference
1.229 (3) 1.461 (3) 1.352 (3) This study
1.224 (2) 1.474 (4) 1.326 (3) Treadwell (2006)
1.227 (4) 1.474 (4) 1.313 (4) Li & Su (1994)
1.240 (2) 1.459 (2) 1.327 (3) Wu et al. (2014b)
1.226 (2) 1.471 (2) 1.325 (2) Tang (2009)
Figure 3
(a) The packing of molecules of I, viewed along the c axis. Molecules are
stacked parallel to the a axis by overlap of each of the three planar
groups. (b) The HSA dnorm map showing the molecular packing. Red
indicates high-intensity contacts and blue indicates low-intensity contacts.
[Symmetry codes: (4) x 1, y, z; (5)x + 2, y 12,z + 1; (6)x + 1, y
1
2,
z + 1; (7) x + 1, y + 12, z + 1.]
3.2. Hirshfeld surface analysis
To help understand the supramolecular arrangement of our
chalcone molecule, Hirshfeld surface analysis (HSA) was
employed (Turner et al., 2017). The de and di surfaces are
illustrated in Fig. 4, where the red spots represent the points of
closest interactions. The combination of di and de on a
‘fingerprint’ plot (Fig. 5) provides more information about all
the contacts in the molecule. In fact, the intermolecular
interactions (C—H  , C—H  Cl, Cl4  Cl2, C—H  O and
–) provide the stabilized molecular packing. These inter-
actions connect the molecules in layers in the crystal packing.
The Hirshfeld surface index map helps to analyse molecular
contacts by colour code: blue indicates low-intensity contacts
and red indicates high-intensity contacts (Aljohani et al.,
2019). The fingerprint plots show that H  H contacts
constitute a high percentage of the interactions in the
compound (37.8%). The C  H/H  C interactions act as
secondary interactions with sharp peaks (14.4%). H  O/
O  H contacts show slightly fewer interactions (12.6%) and
the Cl  H/H  Cl contacts are unexpectedly high (20.6%),
with total di + de (a + b) ’ 2.85 Å, as can be seen in Fig. 5.
Interestingly, – interactions account for 7.8%, indicating
good – stacking. The region marked with a red dotted circle
(light-blue region) represents the – interactions between
rings; these are recognized by C  C contacts. The spikes due
to the C—H  Cl and C  H contacts are pushed farther apart
on the fingerprint plots, with di + de ’ 3.4 Å for each, corre-
sponding to 20.6 and 14.4%, respectively, of all HS inter-
actions.
3.3. Docking analysis
The purpose of this type of docking study, at this critical
time, is to examine how a heterocyclic chalcone-based ligand
might bind in the active site of the main protease for COVID-
19 (Mpro; PDB code 7BQY). Predicting
conformational changes of both the
ligand and 7BQY is a challenge as both
exhibit varying degrees of adjustment
upon binding. Factors such as hydrogen
bonding, hydrophobic interactions, sol-
vation and entropy have direct effects
on the structural reorganization. The
docked molecule, fitted to interact with
the active site of protease 7BQY, is
shown in Fig. 6(b). The conformation of
the chalcone molecule has been
changed considerably from the confor-
mation found in our single-crystal X-ray
study, for a better fit in the site, as
clearly manifested in the different
values of the torsion angles (Table 2). It
has been documented that the Gly143
amino acid residue in Mpro is the most
attractive site for the formation of a
hydrogen bond (Shah et al., 2020); in
our analysis, however, the contact is
Arg188(A) (O)  O2—C13 of 2.89 Å
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Table 4
Hydrogen-bond geometry (Å, ).
D—H  A D—H H  A D  A D—H  A
C13—H13  O7i 0.93 2.42 3.343 (3) 176
C18—H18A  O7i 0.97 2.37 3.326 (3) 168
Symmetry code: (i) x þ 2; y 12;z.
Figure 4
The HSA dnorm map of both sides of the molecule, showing C  O, C  N
and C—Cl  Cl interactions observed between molecules. Blue indicates
low-intensity contacts and red indicates high-intensity contacts.
Figure 5
Hirshfeld surface fingerprint plots of the nearest internal distance (di) versus the nearest external
distance (de) for chalcone I. di and de refer to intra- and intermolecular contacts, respectively.
(Fig. 7a). Cys145, Glu166 and His163 are also strong amino
acid residue candidates to form hydrogen bonds. The chal-
cone-based ligand interacts with 7BQY also through many
hydrophobic interactions (Fig. 6a). A superposition diagram
of the active sites of the 7BQY–N3 compound with the docked
7BQY–chalcone compound was also drawn for best compar-
ison of the docked chalcone compound in the active site of
7BQY (Fig. 6b). The residues of the active site of the protease
7BQY include: Arg188, Gln189, Met165, His164, Glu166,
Cys145, Gly143, Leu167, Pro168, Met49 and His41. The cut-
off for the nonbonded interactions (neglecting H atoms)
between the ligand and the amino acid residues, for the
LIGPLOT representations reported in this article, is 3.9 Å
(Wallace et al., 1995) (Fig. 6a).
Binding affinity is an important key to appreciate the
strength of the binding interaction between the inhibitor
(ligand or drug) and the biomolecule. It is affected by
hydrogen bonding, electrostatic interactions and hydrophobic
and van der Waals forces. The binding affinity obtained for our
chalcone-based ligand with 7BQY is 7.0 kcal mol1. Recent
docking studies on favipiravir, amodiaquine, 20-fluoro-20-de-
oxycytidine, ribavirin, hydroxychloroquine and remdesivir
with 6LU7 showed binding affinities varying from 4.06 to
7.77 kcal mol1; hydroxychloroquine and remdesivir, with
binding affinities of 6.06 and 4.96 kcal mol1, respectively,
were approved drugs as inhibitors to SARS-CoV-2 Mpro
(Hagar et al., 2020). We note, now, however, that the FDA has
recently revoked the approval for hydroxychloroquine
(Thomson & Nachlis, 2020).
However, these and our results are far from the binding
affinities found for disulfiram, trideglusib and shikonin drugs
with 6LU7, viz. 46.16, 61.79 and 47.35 kcal mol1, res-
pectively, reported by Jin et al. (2020).
Further docking studies were performed employing rigid
and flexible binding modes for the chalcone-based ligand for a
comparison of accuracy, time saving and entropy considera-
tions (Alogheli et al., 2017; Lorber & Shoichet, 1998). In rigid
ligand docking mode to the protein binding site, the ligand is
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Table 5













1 7.0 0.0 0.0 1, Arg 188(A), 2.89
2 7.0 1.535 2.045 3, Arg 188(A), 2.70;
Gly 143(A), 3.08;
Thr190(A), 3.10
3 6.9 4.271 9.538 1, His164(A), 2.7
4 6.8 1.291 1.722 1, Glu166(A), 2.68
5 6.7 4.417 9.652 1, Gly143(A), 3.05
6 6.7 5.001 10.53 1, Glu166(A), 3.00
7 6.6 4.414 9.585 0
8 6.6 2.759 3.767 1, Thr190(A), 2.70
9 6.4 1.652 2.114 1, Glu166(A), 2.80
Figure 6
(a) A schematic 2D LIGPLOT representation of the SARS-CoV-2 main protease (Mpro; PDB code 7BQY) complex with chalcone I. The purple–blue
stick, at the centre, represents the ligand, and the brown solid lines represent the active site (residue Arg188) involved in making a hydrogen bond with
the ligand. The green dashed line represents the hydrogen bond and the thin red dashed lines and the spoked arcs pointing towards the ligand represent
the hydrophobic residue bonds with the ligand. All atoms marked by spokes in the ligand or protein indicate atoms which are involved in the
interactions. (b) The superposition of N3 (orange stick) and chalcone I (purple–blue) docked into the binding pocket of 7BQY represented by PyMOL
(DeLano, 2004). The small black window shows the two ligands in wire mode and the 7BQY residues have been omitted for clarity.
rotated relative to the binding site with no conformational
changes of the ligand generated during the docking process.
The binding affinities for the chalcone-based ligand with
7BQY, employing rigid ligand and flexible protein, flexible
ligand and rigid protein, and flexible ligand and flexible
protein are 7.0, 6.8 and 7.1 kcal mol1, respectively.
The binding affinity to the protein target is usually consid-
ered in selecting a possible drug candidate. Pose number 1
shows the highest binding affinity. The intermolecular inter-
actions for the first three poses exhibit hydrogen bonding,
whereas the rest suggest only hydrophobic interactions
(Table 5).
In general, the molecular docking results show that the
effective interactions of proteins with molecules involved the
N and O atoms, and this could be attributed to the presence of
lone-pair electrons on these atoms. Also, – stacking is a
major contributor in hydrophobic interactions.
4. Conclusion
Crystal structure analysis of our chalcone compound shows it
to be an E-isomer and to display significant deviations from
planarity. In the keto–ethene group, the C—C bond is shorter
and the C C bond is longer than in other reported chalcones.
The dihedral angle between the two benzene-ring planes is
60.21 (?), which is larger than in other chalcones and indi-
cates a significant twist in the molecule. The intermolecular
interactions (C—H  , C—H  Cl, C—H  O and –)
provide a stabilized molecular packing. These interactions
connect the molecules to generate layers in the crystal
packing.
Our chalcone derivative has been investigated as an inhi-
bitor for COVID-19 by a molecular docking study. The
binding affinity of the ligand in this study with 7BQY is
7.0 kcal mol1. Interestingly, the result revealed that the
studied chalcone has a comparable binding affinity for SARS-
CoV-2 main protease (PDB code 7BQY) to those of the
approved medicines remdesivir and favipiravir, which have
binding affinities of 6.96 and 4.06 kcal mol1, respectively,
for SARS-CoV-2 main protease (PDB code 6LU7). This
suggests that this chalcone may merit further study in the
context of possible therapeutic agents for COVID-19. The
binding affinity of the ligand with 7BQY was attributed to the
presence of a hydrogen bond and many hydrophobic inter-
actions between the drug and the active amino acid residues of
the receptor.
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single-crystal structure and Hirshfeld surface analysis study
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Computing details 
Data collection: CrysAlis PRO (Rigaku OD, 2019); cell refinement: CrysAlis PRO (Rigaku OD, 2019); data reduction: 
CrysAlis PRO (Rigaku OD, 2019); program(s) used to solve structure: SHELXT (Sheldrick, 2015a); program(s) used to 
refine structure: SHELXL2018 (Sheldrick, 2015b); molecular graphics: ORTEP-3 (Farrugia, 2012); software used to 






a = 3.96521 (9) Å
b = 16.7005 (4) Å
c = 12.4252 (2) Å
β = 91.185 (2)°
V = 822.63 (3) Å3
Z = 2
F(000) = 376
Dx = 1.462 Mg m−3
Cu Kα radiation, λ = 1.54184 Å
Cell parameters from 17383 reflections
θ = 2.6–77.8°
µ = 3.64 mm−1
T = 100 K
Prism, yellow
0.15 × 0.13 × 0.12 mm
Data collection 
Rigaku XtaLAB Synergy Dualflex HyPix 
diffractometer
Radiation source: micro-focus sealed X-ray 
tube, PhotonJet (Cu) X-ray Source
Mirror monochromator
Detector resolution: 10.0000 pixels mm-1
ω scans
Absorption correction: multi-scan 
(CrysAlis PRO; Rigaku OD, 2019)
Tmin = 0.790, Tmax = 1.000
17673 measured reflections
3089 independent reflections
3079 reflections with I > 2σ(I)
Rint = 0.028













Primary atom site location: dual
Hydrogen site location: inferred from 
neighbouring sites
H-atom parameters constrained
w = 1/[σ2(Fo2) + (0.0463P)2 + 0.1638P] 
where P = (Fo2 + 2Fc2)/3
(Δ/σ)max < 0.001
Δρmax = 0.18 e Å−3
Δρmin = −0.20 e Å−3
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Absolute structure: Flack x determined using 
1385 quotients [(I+)-(I-)]/[(I+)+(I-)] (Parsons et 
al., 2013)
Absolute structure parameter: 0.002 (9)
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance 
matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; 
correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate 
(isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Refinement. The crystal used for analysis was a yellow cube cut down from a needle prism to ca 0.12 × 0.13 × 0.15 mm. 
This was mounted in oil on a small loop and fixed in the cold nitrogen stream on a Rigaku Oxford Diffraction XtaLAB 
Synergy diffractometer, equipped with Cu Kα radiation, HyPix detector and mirror monochromator. Intensity data were 
measured by thin-slice ω-scans. Total no. of reflections recorded, to θmax = 72.5°, was 17673 of which 3089 were unique 
(Rint = 0.028); 3079 were 'observed′ with I > 2σI. Data were processed using the CrysAlisPro CCD and RED (Rigaku 
Oxford Diffraction Ltd., 2018) programs. The structure was determined by the intrinsic phasing routines in the SHELXT 
program (Sheldrick, 2015a) and refined by full-matrix least-squares methods, on F2's, in SHELXL (Sheldrick, 2015b). 
The non-hydrogen atoms were refined with anisotropic thermal parameters. 
Scattering factors for neutral atoms were taken from International Tables (1992). Computer programs used in this 
analysis have been noted above, and were run through WinGX (Farrugia, 2012) on a Dell Optiplex 780 PC at the 
University of East Anglia.
The crystallographic data were deposited at the Cambridge Crystallographic Data Centre (CCDC) under a CCDC 
number:2011624. Copies of the data can be obtained, via www. ccdc.cam.ac.uk.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
x y z Uiso*/Ueq
C1 0.9545 (5) 0.73931 (13) 0.27433 (17) 0.0152 (4)
C2 1.0426 (5) 0.73678 (13) 0.38359 (17) 0.0149 (4)
Cl2 1.22361 (12) 0.65138 (3) 0.44086 (4) 0.01875 (13)
C3 1.0024 (6) 0.80261 (15) 0.45034 (16) 0.0163 (4)
H3 1.067736 0.800400 0.522597 0.020*
C4 0.8631 (5) 0.87136 (14) 0.40690 (17) 0.0162 (4)
Cl4 0.81245 (14) 0.95350 (3) 0.49102 (4) 0.02188 (14)
C5 0.7663 (6) 0.87689 (14) 0.29907 (18) 0.0189 (4)
H5 0.670026 0.923528 0.271425 0.023*
C6 0.8174 (6) 0.81078 (14) 0.23391 (17) 0.0186 (4)
H6 0.758946 0.813997 0.161163 0.022*
C7 1.0117 (5) 0.67207 (13) 0.19629 (16) 0.0156 (4)
O7 1.1582 (4) 0.68791 (10) 0.11275 (13) 0.0218 (3)
C8 0.8765 (6) 0.59292 (15) 0.22078 (18) 0.0165 (4)
H8 0.758501 0.585203 0.283861 0.020*
C9 0.9208 (5) 0.53076 (14) 0.15283 (17) 0.0150 (4)
H9 1.047509 0.540990 0.092192 0.018*
C11 0.7933 (5) 0.45028 (14) 0.16393 (16) 0.0151 (4)
C12 0.8317 (5) 0.39453 (14) 0.08094 (17) 0.0160 (4)
H12 0.938062 0.410480 0.018466 0.019*
C13 0.7172 (5) 0.31664 (14) 0.08860 (17) 0.0155 (4)
H13 0.740596 0.281911 0.030725 0.019*
C14 0.5650 (5) 0.28933 (13) 0.18344 (16) 0.0132 (4)
C15 0.5209 (5) 0.34556 (14) 0.26673 (16) 0.0159 (4)
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H15 0.415507 0.329814 0.329461 0.019*
C16 0.6316 (5) 0.42367 (14) 0.25670 (17) 0.0156 (4)
H16 0.598026 0.459444 0.312836 0.019*
N17 0.4798 (4) 0.20947 (12) 0.19637 (14) 0.0145 (4)
C18 0.3753 (5) 0.16042 (14) 0.10351 (16) 0.0165 (4)
H18A 0.500315 0.176468 0.040801 0.020*
H18B 0.137091 0.168634 0.087878 0.020*
C19 0.4400 (6) 0.07279 (14) 0.12729 (18) 0.0187 (4)
H19A 0.363274 0.040835 0.066366 0.022*
H19B 0.680642 0.064173 0.137077 0.022*
O20 0.2701 (4) 0.04708 (10) 0.22196 (13) 0.0193 (3)
C21 0.3857 (5) 0.09365 (14) 0.31143 (17) 0.0177 (4)
H21A 0.625238 0.084422 0.322896 0.021*
H21B 0.270985 0.076053 0.375454 0.021*
C22 0.3253 (5) 0.18248 (14) 0.29586 (17) 0.0161 (4)
H22A 0.084798 0.193057 0.292522 0.019*
H22B 0.421497 0.211782 0.356511 0.019*
Atomic displacement parameters (Å2) 
U11 U22 U33 U12 U13 U23
C1 0.0183 (10) 0.0116 (11) 0.0158 (10) −0.0028 (8) 0.0015 (8) 0.0019 (8)
C2 0.0167 (10) 0.0114 (11) 0.0166 (10) 0.0002 (8) 0.0023 (8) 0.0020 (8)
Cl2 0.0279 (3) 0.0127 (3) 0.0157 (2) 0.00367 (18) −0.00087 (17) 0.00193 (18)
C3 0.0182 (10) 0.0162 (11) 0.0144 (9) −0.0017 (8) 0.0025 (7) 0.0003 (8)
C4 0.0198 (10) 0.0089 (10) 0.0201 (10) −0.0020 (8) 0.0054 (8) −0.0019 (8)
Cl4 0.0339 (3) 0.0124 (3) 0.0196 (2) 0.0030 (2) 0.00575 (19) −0.00228 (19)
C5 0.0226 (11) 0.0131 (11) 0.0210 (11) 0.0018 (8) 0.0007 (8) 0.0033 (8)
C6 0.0267 (11) 0.0139 (11) 0.0151 (9) 0.0008 (8) −0.0014 (8) 0.0018 (8)
C7 0.0190 (10) 0.0139 (12) 0.0139 (9) 0.0001 (8) 0.0000 (8) 0.0019 (8)
O7 0.0327 (8) 0.0164 (9) 0.0164 (7) −0.0016 (6) 0.0067 (6) 0.0020 (6)
C8 0.0193 (10) 0.0149 (11) 0.0154 (10) −0.0013 (8) 0.0027 (7) 0.0009 (8)
C9 0.0160 (10) 0.0155 (12) 0.0135 (9) 0.0009 (8) 0.0007 (7) 0.0023 (8)
C11 0.0160 (9) 0.0145 (11) 0.0148 (9) 0.0029 (8) 0.0003 (7) 0.0002 (8)
C12 0.0187 (10) 0.0150 (11) 0.0144 (9) 0.0014 (8) 0.0029 (8) 0.0012 (8)
C13 0.0190 (10) 0.0133 (11) 0.0143 (9) 0.0021 (8) 0.0011 (7) −0.0010 (8)
C14 0.0130 (9) 0.0118 (11) 0.0146 (9) 0.0012 (7) −0.0013 (7) −0.0002 (8)
C15 0.0183 (10) 0.0167 (11) 0.0127 (9) 0.0008 (8) 0.0023 (7) −0.0008 (8)
C16 0.0194 (10) 0.0134 (11) 0.0142 (9) 0.0001 (8) 0.0016 (8) −0.0019 (8)
N17 0.0176 (8) 0.0120 (10) 0.0139 (8) −0.0009 (7) 0.0014 (6) −0.0008 (7)
C18 0.0186 (9) 0.0152 (12) 0.0156 (9) −0.0017 (8) −0.0004 (7) −0.0004 (9)
C19 0.0191 (10) 0.0155 (12) 0.0214 (11) −0.0017 (8) −0.0003 (8) −0.0016 (9)
O20 0.0201 (8) 0.0150 (9) 0.0227 (8) −0.0043 (6) −0.0010 (6) 0.0017 (6)
C21 0.0168 (10) 0.0158 (11) 0.0204 (10) −0.0016 (8) −0.0011 (8) 0.0031 (8)
C22 0.0170 (10) 0.0165 (12) 0.0148 (9) −0.0018 (8) 0.0005 (7) 0.0019 (8)
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Geometric parameters (Å, º) 
C1—C2 1.396 (3) C13—C14 1.411 (3)
C1—C6 1.400 (3) C13—H13 0.9300
C1—C7 1.504 (3) C14—N17 1.386 (3)
C2—C3 1.388 (3) C14—C15 1.411 (3)
C2—Cl2 1.742 (2) C15—C16 1.383 (3)
C3—C4 1.379 (3) C15—H15 0.9300
C3—H3 0.9300 C16—H16 0.9300
C4—C5 1.389 (3) N17—C22 1.462 (3)
C4—Cl4 1.739 (2) N17—C18 1.468 (3)
C5—C6 1.387 (3) C18—C19 1.514 (3)
C5—H5 0.9300 C18—H18A 0.9700
C6—H6 0.9300 C18—H18B 0.9700
C7—O7 1.229 (3) C19—O20 1.433 (3)
C7—C8 1.461 (3) C19—H19A 0.9700
C8—C9 1.352 (3) C19—H19B 0.9700
C8—H8 0.9300 O20—C21 1.425 (3)
C9—C11 1.444 (3) C21—C22 1.514 (3)
C9—H9 0.9300 C21—H21A 0.9700
C11—C12 1.400 (3) C21—H21B 0.9700
C11—C16 1.403 (3) C22—H22A 0.9700
C12—C13 1.382 (3) C22—H22B 0.9700
C12—H12 0.9300
C2—C1—C6 117.5 (2) N17—C14—C15 121.41 (19)
C2—C1—C7 124.5 (2) C13—C14—C15 117.3 (2)
C6—C1—C7 117.90 (18) C16—C15—C14 121.16 (19)
C3—C2—C1 121.8 (2) C16—C15—H15 119.4
C3—C2—Cl2 117.12 (16) C14—C15—H15 119.4
C1—C2—Cl2 121.00 (17) C15—C16—C11 121.6 (2)
C4—C3—C2 118.39 (19) C15—C16—H16 119.2
C4—C3—H3 120.8 C11—C16—H16 119.2
C2—C3—H3 120.8 C14—N17—C22 120.14 (18)
C3—C4—C5 122.2 (2) C14—N17—C18 120.77 (17)
C3—C4—Cl4 118.15 (17) C22—N17—C18 112.09 (17)
C5—C4—Cl4 119.62 (18) N17—C18—C19 110.01 (17)
C6—C5—C4 118.0 (2) N17—C18—H18A 109.7
C6—C5—H5 121.0 C19—C18—H18A 109.7
C4—C5—H5 121.0 N17—C18—H18B 109.7
C5—C6—C1 122.0 (2) C19—C18—H18B 109.7
C5—C6—H6 119.0 H18A—C18—H18B 108.2
C1—C6—H6 119.0 O20—C19—C18 111.65 (18)
O7—C7—C8 123.6 (2) O20—C19—H19A 109.3
O7—C7—C1 117.66 (19) C18—C19—H19A 109.3
C8—C7—C1 118.71 (18) O20—C19—H19B 109.3
C9—C8—C7 120.8 (2) C18—C19—H19B 109.3
C9—C8—H8 119.6 H19A—C19—H19B 108.0
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C7—C8—H8 119.6 C21—O20—C19 109.14 (16)
C8—C9—C11 127.2 (2) O20—C21—C22 112.81 (17)
C8—C9—H9 116.4 O20—C21—H21A 109.0
C11—C9—H9 116.4 C22—C21—H21A 109.0
C12—C11—C16 116.9 (2) O20—C21—H21B 109.0
C12—C11—C9 120.35 (19) C22—C21—H21B 109.0
C16—C11—C9 122.7 (2) H21A—C21—H21B 107.8
C13—C12—C11 122.3 (2) N17—C22—C21 110.01 (18)
C13—C12—H12 118.8 N17—C22—H22A 109.7
C11—C12—H12 118.8 C21—C22—H22A 109.7
C12—C13—C14 120.6 (2) N17—C22—H22B 109.7
C12—C13—H13 119.7 C21—C22—H22B 109.7
C14—C13—H13 119.7 H22A—C22—H22B 108.2
N17—C14—C13 121.16 (19)
C6—C1—C2—C3 −1.0 (3) C16—C11—C12—C13 0.0 (3)
C7—C1—C2—C3 176.0 (2) C9—C11—C12—C13 179.2 (2)
C6—C1—C2—Cl2 −178.56 (17) C11—C12—C13—C14 −2.2 (3)
C7—C1—C2—Cl2 −1.6 (3) C12—C13—C14—N17 −173.46 (19)
C1—C2—C3—C4 1.7 (3) C12—C13—C14—C15 3.0 (3)
Cl2—C2—C3—C4 179.31 (17) N17—C14—C15—C16 174.66 (19)
C2—C3—C4—C5 −0.7 (3) C13—C14—C15—C16 −1.8 (3)
C2—C3—C4—Cl4 179.84 (16) C14—C15—C16—C11 −0.3 (3)
C3—C4—C5—C6 −0.9 (3) C12—C11—C16—C15 1.2 (3)
Cl4—C4—C5—C6 178.58 (17) C9—C11—C16—C15 −178.0 (2)
C4—C5—C6—C1 1.5 (3) C13—C14—N17—C22 179.40 (18)
C2—C1—C6—C5 −0.6 (3) C15—C14—N17—C22 3.0 (3)
C7—C1—C6—C5 −177.8 (2) C13—C14—N17—C18 −32.2 (3)
C2—C1—C7—O7 −128.3 (2) C15—C14—N17—C18 151.44 (19)
C6—C1—C7—O7 48.7 (3) C14—N17—C18—C19 155.90 (18)
C2—C1—C7—C8 54.8 (3) C22—N17—C18—C19 −53.4 (2)
C6—C1—C7—C8 −128.2 (2) N17—C18—C19—O20 57.1 (2)
O7—C7—C8—C9 3.1 (4) C18—C19—O20—C21 −59.5 (2)
C1—C7—C8—C9 179.78 (19) C19—O20—C21—C22 58.9 (2)
C7—C8—C9—C11 −177.70 (19) C14—N17—C22—C21 −156.88 (18)
C8—C9—C11—C12 173.4 (2) C18—N17—C22—C21 52.2 (2)
C8—C9—C11—C16 −7.4 (4) O20—C21—C22—N17 −55.5 (2)
Hydrogen-bond geometry (Å, º) 
D—H···A D—H H···A D···A D—H···A
C13—H13···O7i 0.93 2.42 3.343 (3) 176
C18—H18A···O7i 0.97 2.37 3.326 (3) 168
Symmetry code: (i) −x+2, y−1/2, −z.
